Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
€ 35,82 ↓ -1.80 (-4.78%)
2026-06-05
PREÇO DA AÇÃO
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionRathbone Brothers plc
Latest Disclosed Ownership81,882 shares
Latest Disclosed Value $ 3,009,163
Rathbone Brothers plc reports 11.96% increase in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 12, 2026 - Rathbone Brothers plc filed a 13F-HR form disclosing ownership of 81,882 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $2,583,377 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 6, 2026 disclosing 73,138 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 11.96% during the quarter. The current value of the position is $2,933,013 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 81,882 8,744 11.96 3,009 -19.13 0.0129
2026-02-06 2025-12-31 13F/A-1 NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 73,138 32,270 78.96 3,721 64.14 0.0147
2026-01-21 2025-12-31 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 73,138 32,270 3,721 0.0147
2025-11-13 2025-09-30 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 40,868 -1,180 -2.81 2,268 -21.88 0.0092
2025-08-07 2025-06-30 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 42,048 42 0.10 2,902 -0.48 0.0125
2025-05-13 2025-03-31 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 42,006 29,993 249.67 2,917 182.28 0.0141
2025-02-13 2024-12-31 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 12,013 -562 -4.47 1,033 -31.00 0.0050
2024-11-13 2024-09-30 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 12,575 1,805 16.76 1,497 -2.60 0.0076
2024-08-09 2024-06-30 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 10,770 -6,015 -35.84 1,537 -28.68 0.0084
2024-05-14 2024-03-31 13F Novo Nordisk A COM 670100205 16,785 265 1.60 2,155 26.17 0.0124
2024-02-13 2023-12-31 13F Novo Nordisk A COM 670100205 16,520 -28 -0.17 1,709 13.56 0.0110
2023-11-13 2023-09-30 13F Novo Nordisk A COM 670100205 16,548 16,548 1,505 0.0109
2023-02-14 2022-12-31 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 0 -2,500 -100.00 0 -100.00
2022-11-14 2022-09-30 13F/A-1 NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 2,500 0 0.00 249 -10.75 0.0031
2022-11-03 2022-09-30 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 2,500 0 249 0.0031
2022-08-12 2022-06-30 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 2,500 0 0.00 279 0.36 0.0032
2022-05-11 2022-03-31 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 2,500 0 0.00 278 -0.71 0.0028
2022-02-10 2021-12-31 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 2,500 0 0.00 280 16.67 0.0027
2021-11-04 2021-09-30 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 2,500 0 0.00 240 14.83 0.0026
2021-07-30 2021-06-30 13F NOVO-NORDISK AS ADR Rep 1 DKK1 Cls B Shares COM 670100205 2,500 2,500 209 0.0023
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.